Singapore · Biotechnology startup
Singapore · DotBio
DotBio develops multi-functional antibodies based on its proprietary DotBody technology as the next generation of cancer therapies.
Funding reportedLast round: Seed
Follow DotBio and see its new rounds in your feed.Start following
What company datasets say DotBio raised
Funding, as reported
Reported in all8.1Min the source's currency
Rounds4
Last roundSeed
Last round dateAug 2023
Investors listed4
Biotechnology in Singapore
Startups like it
ASLAN PharmaceuticalsSingapore · founded 2010
RVAC Medicines Pte. Ltd.Singapore · founded 2021
MirxesSingapore · founded 2014
Apeiron BioenergySingapore · founded 2007
Eywa Pharmafounded 2015
Curiox BiosystemsSingapore · founded 2008
Aevice HealthSingapore · founded 2016- SCG Cell TherapySingapore · founded 2017
Is this your company?
Add your raise, your deck and your story, and put DotBio in front of investors. Or tell us what we have wrong.